Medicare Enrolled
Dr. Neelema Pinnapureddy, DO
Hematology & Oncology · Irving, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pinnapureddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pinnapureddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pinnapureddy
Dr. Neelema Pinnapureddy is a hematology & oncology specialist in Irving, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Pinnapureddy performed 689 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pinnapureddy received a total of $5,750 from 67 pharmaceutical and/or device companies across 240 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pinnapureddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ 689 Medicare services
$5,750 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗689
Medicare services
Bottom 39% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $97 | $275 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
146 | $8 | $32 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
121 | $10 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
94 | $8 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $140 | $350 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
39 | $102 | $412 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $70 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $92 | $239 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $123 | $400 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
16 | $53 | $401 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.7% high complexity
2.3% medium
92.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,750
Total received (2018-2024)
Avg $821/year across 7 years
Top 41% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
240
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,654
2023
$1,628
2022
$1,172
2021
$108
2020
$15
2019
$42
2018
$132
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$390
Merck Sharp & Dohme LLC
$163
PFIZER INC.
$149
Astellas Pharma US Inc
$148
Daiichi Sankyo Inc.
$146
Novartis Pharmaceuticals Corporation
$136
Janssen Biotech, Inc.
$131
Celgene Corporation
$106
ABBVIE INC.
$104
GENZYME CORPORATION
$82
Eisai Inc.
$79
GlaxoSmithKline, LLC.
$75
Legend Biotech USA Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$59
Lilly USA, LLC
$56
Karyopharm Therapeutics Inc.
$50
Octapharma USA, Inc.
$50
Gilead Sciences, Inc.
$48
Blue Earth Diagnostics Limited
$42
ARRAY BIOPHARMA INC
$40
SOBI, INC
$39
ADC Therapeutics America, Inc.
$37
Verity Pharmaceuticals Inc.
$36
PharmaEssentia USA Corporation
$35
Aveo Pharmaceuticals, Inc.
$34
Genmab U.S., Inc.
$31
Deciphera Pharmaceuticals Inc.
$29
Rigel Pharmaceuticals, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Kyowa Kirin, Inc.
$24
Incyte Corporation
$24
Regeneron Healthcare Solutions, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$22
Mirati Therapeutics, Inc.
$22
Stemline Therapeutics Inc.
$22
Blueprint Medicines Corporation
$20
TAIHO ONCOLOGY, INC.
$19
Immunocore Limited
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
Acrotech Biopharma Inc.
$15
Top 3 companies account for 26.5% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$651
AstraZeneca Pharmaceuticals LP
$457
Janssen Biotech, Inc.
$297
Merck Sharp & Dohme LLC
$291
Novartis Pharmaceuticals Corporation
$279
E.R. Squibb & Sons, L.L.C.
$240
PFIZER INC.
$236
Astellas Pharma US Inc
$217
Celgene Corporation
$210
Stemline Therapeutics Inc.
$165
Sirtex Medical Inc
$135
GlaxoSmithKline, LLC.
$126
GENZYME CORPORATION
$123
Amgen Inc.
$112
ABBVIE INC.
$104
Eisai Inc.
$97
Lilly USA, LLC
$92
Gilead Sciences, Inc.
$91
Karyopharm Therapeutics Inc.
$91
Incyte Corporation
$75
Myriad Genetic Laboratories, Inc.
$73
Foundation Medicine, Inc.
$68
ADC Therapeutics America, Inc.
$67
Legend Biotech USA Inc.
$65
Kite Pharma, Inc.
$62
PharmaEssentia USA Corporation
$62
Rigel Pharmaceuticals, Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$59
Blue Earth Diagnostics Limited
$56
Regeneron Healthcare Solutions, Inc.
$53
Genentech USA, Inc.
$52
Octapharma USA, Inc.
$50
Mirati Therapeutics, Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
ARRAY BIOPHARMA INC
$40
SOBI, INC
$39
Agios Pharmaceuticals, Inc.
$37
Immunocore Limited
$37
Verity Pharmaceuticals Inc.
$36
Pharmacyclics LLC, An AbbVie Company
$35
Aveo Pharmaceuticals, Inc.
$34
Merck Sharp & Dohme Corporation
$34
Acrotech Biopharma Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$32
Genmab U.S., Inc.
$31
Deciphera Pharmaceuticals Inc.
$29
CTI BioPharma Corp.
$28
Sun Pharmaceutical Industries Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Kyowa Kirin, Inc.
$24
Coherus Biosciences Inc.
$24
Telix Pharmaceuticals
$24
Exelixis Inc.
$23
Clovis Oncology, Inc.
$23
Jazz Pharmaceuticals Inc.
$23
EISAI INC.
$21
Adaptive Biotechnologies Corporation
$21
Blueprint Medicines Corporation
$20
PUMA BIOTECHNOLOGY, INC.
$20
TAIHO ONCOLOGY, INC.
$19
Secura Bio, Inc.
$18
G1 Therapeutics, Inc.
$18
Progenics Pharmaceuticals, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Lexicon Pharmaceuticals, Inc.
$15
EMD Serono, Inc.
$13
Seattle Genetics, Inc.
$11
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · AMYVID · AYVAKIT · Alecensa · Axumin · BELEODAQ · BESREMI · BOSULIF · CABLIVI · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELAHERE · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EndoPredict · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · NERLYNX · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OXBRYTA · Orserdu · PLUVICTO · POSLUMA · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Tivdak · Trelstar · Trodelvy · Udenyca · VERZENIO · VONJO · Vanflyta · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
159
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR SURGICAL HOSPITAL AT LAS COLINAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pinnapureddy is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pinnapureddy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pinnapureddy performed 164 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pinnapureddy receive payments from pharmaceutical companies?
Yes. Dr. Pinnapureddy received a total of $5,750 from 67 companies across 240 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pinnapureddy's costs compare to other hematology & oncology specialists in Irving?
Dr. Pinnapureddy's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pinnapureddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Irving
Browse hematology & oncology specialists in Irving ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology